At #ASCO26, Dr. Xiuning Le highlighted emerging data on zongertinib and sevabertinib for patients with nonsquamous non–small cell lung cancer, underscoring ongoing progress in precision oncology and biomarker-driven treatment strategies. @LeXiuning#EndCancer
@GloriaCampos Yours is an elite breakfast order which I love, but as someone who is Latina and grew up in the RGV we ate papas con huevos en tortilla de harina a lot too, especially during Lent 🙏🏻❤️